Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation

CompletedOBSERVATIONAL
Enrollment

279

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2010

Conditions
STERILITY
Interventions
DRUG

hMG-HP

Trial Locations (14)

Unknown

Investigational site, Albacete

Investigational site, Alicante

Investigational site, Elche

Investigational site, Badajoz

Investigational site, Castellon

Investigational site, Santiago de Compostela

Investigational site, Mallorca

Investigational site, Murcia

Investigational site, Málaga

Investigational site, Navarra

Investigational site, Gijón

Investigational site Sta. Cruz, Santa Cruz de Tenerife

Investigational site, Valencia

Investigational site, Zaragoza

Sponsors
All Listed Sponsors
collaborator

Ferring SAU

INDUSTRY

lead

Ferring Pharmaceuticals

INDUSTRY

NCT01331720 - Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation | Biotech Hunter | Biotech Hunter